For this installment of Teach Me in 10, we are joined by the renowned Professor Robert Langer – the most cited engineer of all time – who talks to us about materials for drug delivery.Watch Now
Checkpoint inhibitors are a type of immunotherapy. They block proteins that stop the immune system from attacking the cancer cells. Find out how these work and when you might have them as a treatment for cancer.Watch Now
Interim analysis of Oxford University's COVID-19 vaccine suggests an efficacy of 70.4%.
What does the COVID-19 Vaccine Efficacy actually mean? It's not what you think. Unless you’ve been living under a rock these past two weeks, you probably heard the great news that two of the leading vaccine contenders for COVID-19 have had some amazing initial results. Jeff Galak debunks some of the most common incorrect interpretation of those efficacy numbers and then explains to you what they actually mean.Watch Now
In the last week, twin announcements from Pfizer and the Gamaleya Institute have suggested a vaccine for COVID-19 will prove effective at cutting infection rates. With only a minimal amount of analysis released, can we get excited about 2021 yet?Watch Now
In this installment of Teach Me in 10, we're joined by Ross Ashdown, who talks us through the basic concepts of inductively coupled plasma-optical emission spectrometry, or ICP-OES.Watch Now
Traditionally data acquisition has been the bottleneck for large scale proteomics. This has also remained one of the limitations in leveraging mass spectrometry within the clinic.Watch Now